Luis Cano

508 total citations
34 papers, 330 citations indexed

About

Luis Cano is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Luis Cano has authored 34 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Hepatology and 8 papers in Oncology. Recurrent topics in Luis Cano's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Luis Cano is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Luis Cano collaborates with scholars based in France, Peru and Spain. Luis Cano's co-authors include Miluska Castillo, Sandro Casavilca‐Zambrano, César Beltrán, Pascal Pineau, Stéphane Bertani, Eloy Ruíz, Eric Deharo, Agnès Marchio, Nicolas Golse and Daniel Cherqui and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Scientific Reports.

In The Last Decade

Luis Cano

32 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis Cano France 10 101 93 77 75 60 34 330
Wenda Xu China 11 54 0.5× 48 0.5× 62 0.8× 72 1.0× 84 1.4× 36 334
Ying Lv China 11 167 1.7× 67 0.7× 93 1.2× 77 1.0× 127 2.1× 26 360
Chuanhai Zhang China 9 92 0.9× 56 0.6× 37 0.5× 140 1.9× 79 1.3× 22 337
Modan Yang China 9 71 0.7× 86 0.9× 88 1.1× 103 1.4× 76 1.3× 26 308
Gwyneth Shook Ting Soon Singapore 10 72 0.7× 76 0.8× 92 1.2× 48 0.6× 60 1.0× 26 272
Wenyu Zhang China 12 116 1.1× 51 0.5× 55 0.7× 119 1.6× 31 0.5× 40 391
Ha Il Kim South Korea 10 63 0.6× 93 1.0× 77 1.0× 39 0.5× 52 0.9× 29 257
Ali Morshid United States 8 52 0.5× 132 1.4× 62 0.8× 119 1.6× 86 1.4× 15 398
Markus Casper Germany 11 98 1.0× 41 0.4× 63 0.8× 58 0.8× 151 2.5× 40 401

Countries citing papers authored by Luis Cano

Since Specialization
Citations

This map shows the geographic impact of Luis Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Cano more than expected).

Fields of papers citing papers by Luis Cano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Cano. The network helps show where Luis Cano may publish in the future.

Co-authorship network of co-authors of Luis Cano

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Cano. A scholar is included among the top collaborators of Luis Cano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Cano. Luis Cano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rauch, Claudine, Tifenn Le Charpentier, Luis Cano, et al.. (2025). PPARγ, a key modulator of metabolic reprogramming, stemness and chemoresistance associated with retrodifferentiation in human hepatocellular carcinomas. Cell Death and Disease. 16(1). 831–831.
2.
Cano, Luis, Daniel Pietrasz, Nassiba Beghdadi, et al.. (2024). Liver Transplantation from Elderly Donors (≥85 Years Old). Cancers. 16(10). 1803–1803. 1 indexed citations
3.
Cano, Luis, et al.. (2024). Lessons learned from the sustainable recycling process of a wind blade made with a new thermoplastic resin. Journal of Physics Conference Series. 2767(7). 72008–72008. 2 indexed citations
4.
Cano, Luis, et al.. (2023). Analysis of a small recyclable wind turbine blade. IOP Conference Series Materials Science and Engineering. 1293(1). 12008–12008. 1 indexed citations
5.
Cano, Luis, Gaëlle Angenard, Anne Corlu, et al.. (2023). SARS-CoV-2 receptor ACE2 is upregulated by fatty acids in human MASH. JHEP Reports. 6(1). 100936–100936. 5 indexed citations
6.
Labgaa, Ismaïl, Luis Cano, Gaëtan‐Romain Joliat, et al.. (2022). An algorithm based on the postoperative decrease of albumin (ΔAlb) to anticipate complications after liver surgery. SHILAP Revista de lepidopterología. 11(1). 53–53. 2 indexed citations
7.
Cano, Luis, Marc‐Antoine Allard, Oriana Ciacio, et al.. (2022). Resectable and transplantable hepatocellular carcinoma: Integration of liver stiffness assessment in the decision-making algorithm. Surgery. 172(6). 1704–1711. 4 indexed citations
8.
Cano, Luis, Nicolas Mouchet, Anne Corlu, et al.. (2022). Well-differentiated liver cancers reveal the potential link between ACE2 dysfunction and metabolic breakdown. Scientific Reports. 12(1). 1859–1859. 7 indexed citations
9.
Pineau, Pascal, Claudio Flores, Luis Cano, et al.. (2021). A preoperative nomogram for predicting long-term survival after resection of large hepatocellular carcinoma (>10 cm). HPB. 24(2). 192–201. 12 indexed citations
10.
Reste, Pierre‐Jean Le, Eleftherios Pilalis, Marc Aubry, et al.. (2021). Integration of Raman spectra with transcriptome data in glioblastoma multiforme defines tumour subtypes and predicts patient outcome. Journal of Cellular and Molecular Medicine. 25(23). 10846–10856. 9 indexed citations
11.
Golse, Nicolas, Luis Cano, Marc‐Antoine Allard, et al.. (2020). Spleen volumetry and liver transient elastography: Predictors of persistent posthepatectomy decompensation in patients with hepatocellular carcinoma. Surgery. 168(1). 17–24. 8 indexed citations
12.
Robin, Fabien, Gaëlle Angenard, Luis Cano, et al.. (2020). Molecular profiling of stroma highlights stratifin as a novel biomarker of poor prognosis in pancreatic ductal adenocarcinoma. British Journal of Cancer. 123(1). 72–80. 24 indexed citations
13.
Núñez, Julio, Luis Cano, Marc‐Antoine Allard, et al.. (2020). Predictors of unresectability after portal vein embolization for centrally located cholangiocarcinoma. Surgery. 168(2). 287–296. 5 indexed citations
14.
Marchio, Agnès, Eloy Ruíz, Luis Cano, et al.. (2018). Early-onset liver cancer in South America associates with low hepatitis B virus DNA burden. Scientific Reports. 8(1). 12031–12031. 23 indexed citations
15.
Cano, Luis, Eloy Ruíz, Agnès Marchio, et al.. (2018). Liver clear cell foci and viral infection are associated with non-cirrhotic, non-fibrolamellar hepatocellular carcinoma in young patients from South America. Scientific Reports. 8(1). 9945–9945. 7 indexed citations
16.
Castañeda, Carlos A., Carlos A. Torres‐Cabala, Miluska Castillo, et al.. (2017). Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America. Clinical & Translational Oncology. 19(12). 1478–1488. 41 indexed citations
17.
Ruíz, Eloy, Luis Cano, Franco D. Doimi, et al.. (2016). Hepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru. Heliyon. 2(1). e00052–e00052. 21 indexed citations
18.
19.
Barrios, Yvelise, et al.. (1998). Domino (crossover) kidney transplantation using low doses of neoral. Transplantation Proceedings. 30(5). 2289–2290. 4 indexed citations
20.
Barrios, Yvelise, et al.. (1998). Cyclosporine: has it made a difference between using HLA or not? a comparative study between patients with and without HLA matching. Transplantation Proceedings. 30(5). 1744–1745. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenda Xu Breakdown of academic impact, for papers by Ying Lv Breakdown of academic impact, for papers by Chuanhai Zhang Breakdown of academic impact, for papers by Modan Yang Breakdown of academic impact, for papers by Gwyneth Shook Ting Soon Breakdown of academic impact, for papers by Wenyu Zhang Breakdown of academic impact, for papers by Ha Il Kim Breakdown of academic impact, for papers by Ali Morshid Breakdown of academic impact, for papers by Markus Casper
Rankless by CCL
2026